Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125322671 | 12532267 | 1 | I | 20160623 | 20160706 | 20160706 | EXP | GB-MHRA-EYC 00141319 | GB-TEVA-671552ACC | TEVA | 86.00 | YR | F | Y | 0.00000 | 20160706 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125322671 | 12532267 | 1 | PS | WARFARIN | WARFARIN | 1 | Oral | U | 40145 | ||||||||||
125322671 | 12532267 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | ||||||||||||
125322671 | 12532267 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
125322671 | 12532267 | 4 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
125322671 | 12532267 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125322671 | 12532267 | 1 | Pulmonary embolism |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125322671 | 12532267 | DE |
125322671 | 12532267 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125322671 | 12532267 | Depressed level of consciousness | |
125322671 | 12532267 | Fall | |
125322671 | 12532267 | Subdural haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125322671 | 12532267 | 1 | 20160406 | 0 |